Skip to main content
. 2017 Aug 2;6(7):423–432. doi: 10.1302/2046-3758.67.BJR-2017-0027.R1

Table III.

Search results of systematic literature search

Products Inclusion Exclusion Final
PubMed Embase In vitro experiments Animal experiments Non-trauma- or orthopaedic-related indication Additional references
papers (n) Eligible papers (n) Eligible Duplicates Total
Accell Connexus (Citagenix, Laval, Canada) 2 2 7 3 1 4 1 2 0 0 1
Accell TBM (Integra, Irvine, California) 0 0 3 1 0 1 1 0 0 0 0
AlloCraft (Stryker, Mahwah, New Jersey) 1 1 1 1 1 1 0 1 0 0 0
Allomatrix (Wright Medical, London, United Kingdom) 13 13 52 24 13 24 3 6 1 4 18
AlphaGRAFT (Alphatech, Carlsbad, California) 0 0 0 0 0 0 0 0 0 0 0
Altiva (Exactech, Gainesville, Florida) 1 1 3 1 1 1 0 0 1 0 0
BioSet (Penta Biomedical, Verona, Italy) 2 2 5 2 2 2 0 2 0 0 0
DBX (DePuy Synthes, Zuchwil, Switzerland) 25 24 66 31 20 35 6 18 6 0 5
Grafton DBM (Osteotech, Eatontown, New Jersey) 181 46 371 57 42 61 5 20 6 3 33
InterGro (Zimmer Biomet, Westminster, California) 1 1 5 2 1 2 1 1 0 0 0
Optefil (Exactech) 0 0 0 0 0 0 0 0 0 0 0
Opteform (Exactech) 0 0 16 2 0 2 0 1 0 1 2
Optium DBM (DePuy. Warsaw, Indiana) 0 0 2 0 0 0 0 0 0 0 0
OrthoBlast (Citagenix) 7 4 20 5 4 5 1 0 1 0 3
OrthoBlast II (Citagenix) 4 4 4 4 4 4 0 0 4 0 0
Osteofil (Medtronic. Minneapolis, Minnesota) 5 4 25 8 4 8 1 5 0 0 2
VIAGRAF (Smith & Nephew. London, United Kingdom) 0 0 1 0 0 0 0 0 0 0 0